1
|
Cole PJ: Inflammation: A two-edged sword -
the model of bronchiectasis. Eur J Respir Dis Suppl. 147:6–15.
1986.PubMed/NCBI
|
2
|
O'Donnell AE: Bronchiectasis update. Curr
Opin Infect Dis. 31:194–198. 2018.PubMed/NCBI View Article : Google Scholar
|
3
|
Lonni S, Chalmers JD, Goeminne PC,
McDonnell MJ, Dimakou K, De Soyza A, Polverino E, Van de Kerkhove
C, Rutherford R, Davison J, et al: Etiology of non-cystic fibrosis
bronchiectasis in adults and its correlation to disease severity.
Ann Am Thorac Soc. 12:1764–1770. 2015.PubMed/NCBI View Article : Google Scholar
|
4
|
Georgakopoulou VE, Trakas N, Damaskos C,
Garmpis N, Karakou E, Chatzikyriakou R, Lambrou P and Tsiafaki X:
Neutrophils to lymphocyte ratio as a biomarker in bronchiectasis
exacerbation: A retrospective study. Cureus.
12(e9728)2020.PubMed/NCBI View Article : Google Scholar
|
5
|
Wilson R, Aksamit T, Aliberti S, De Soyza
A, Elborn JS, Goeminne P, Hill AT, Menendez R and Polverino E:
Challenges in managing Pseudomonas aeruginosa in non-cystic
fibrosis bronchiectasis. Respir Med. 117:179–189. 2016.PubMed/NCBI View Article : Google Scholar
|
6
|
Li X, Yin D, Yang Y, Bi C, Wang Z, Ma G,
Fu X, Ji S, Jiang F and Yu T: Eosinophil: A nonnegligible predictor
in COVID-19 re-positive patients. Front Immunol.
12(690653)2021.PubMed/NCBI View Article : Google Scholar
|
7
|
Lansbury L, Lim B, Baskaran V and Lim WS:
Co-infections in people with COVID-19: A systematic review and
meta-analysis. J Infect. 81:266–275. 2020.PubMed/NCBI View Article : Google Scholar
|
8
|
Langford BJ, So M, Raybardhan S, Leung V,
Westwood D, MacFadden DR, Soucy JR and Daneman N: Bacterial
co-infection and secondary infection in patients with COVID-19: A
living rapid review and meta-analysis. Clin Microbiol Infect.
26:1622–1629. 2020.PubMed/NCBI View Article : Google Scholar
|
9
|
Crichton ML, Shoemark A and Chalmers JD:
The impact of the COVID-19 pandemic on exacerbations and symptoms
in bronchiectasis: A prospective study. Am J Respir Crit Care Med.
204:857–859. 2021.PubMed/NCBI View Article : Google Scholar
|
10
|
Volke DC, Calero P and Nikel PI:
Pseudomonas putida . Trends Microbiol. 28:512–513.
2020.PubMed/NCBI View Article : Google Scholar
|
11
|
Yang CH, Young T, Peng MY and Weng MC:
Clinical spectrum of Pseudomonas putida infection. J Formos
Med Assoc. 95:754–761. 1996.PubMed/NCBI
|
12
|
Neulier C, Breton N, Pangon B, Le Monnier
A, Henry-Lagarrigue M, Dujon C and Merrer J: Pseudo-outbreak of
Pseudomonas putida respiratory infection caused by
laboratory contamination. Infect Control Hosp Epidemiol.
32:523–525. 2011.PubMed/NCBI View
Article : Google Scholar
|
13
|
Fujita J, Negayama K, Ohara M, Hojo S,
Obayashi Y, Miyawaki H, Yamaji Y and Takahara J: Pneumonia caused
by Pseudomonas putida with a mucoid phenotype. Respir Med.
92:693–695. 1998.PubMed/NCBI View Article : Google Scholar
|
14
|
Peter S, Oberhettinger P, Schuele L,
Dinkelacker A, Vogel W, Dörfel D, Bezdan D, Ossowski S, Marschal M,
Liese J, et al: Genomic characterisation of clinical and
environmental Pseudomonas putida group strains and
determination of their role in the transfer of antimicrobial
resistance genes to Pseudomonas aeruginosa. BMC Genomics.
18(859)2017.PubMed/NCBI View Article : Google Scholar
|
15
|
Metersky ML: Fewer bronchiectasis
exacerbations during the ‘Lockdown’ for COVID-19: Can we convert
knowledge into action? Am J Respir Crit Care Med. 204:759–760.
2021.PubMed/NCBI View Article : Google Scholar
|
16
|
Lopinto J, Teulier M, Milon A, Voiriot G
and Fartoukh M: Severe hemoptysis in post-tuberculosis
bronchiectasis precipitated by SARS-CoV-2 infection. BMC Pulm Med.
20(244)2020.PubMed/NCBI View Article : Google Scholar
|
17
|
Faqihi F, Alharthy A, Pirompanich P, Noor
A, Shahzad A, Nasim N, Balhamar A, Memish ZA and Karakitsos D:
Co-infection of SARS-CoV-2 and Bordetella bronchiseptica in
a young man with idiopathic non-cystic bronchiectasis and vitamin
D3 deficiency. Respir Med Case Rep. 31(101203)2020.PubMed/NCBI View Article : Google Scholar
|
18
|
Yang J, Zheng Y, Gou X, Pu K, Chen Z, Guo
Q, Ji R, Wang H, Wang Y and Zhou Y: Prevalence of comorbidities and
its effects in patients infected with SARS-CoV-2: A systematic
review and meta-analysis. Int J Infect Dis. 94:91–95.
2020.PubMed/NCBI View Article : Google Scholar
|
19
|
Wu Z and McGoogan JM: Characteristics of
and important lessons from the Coronavirus Disease 2019 (COVID-19)
outbreak in China: Summary of a report of 72,314 cases from the
Chinese Center for Disease Control and Prevention. JAMA.
323:1239–1242. 2020.PubMed/NCBI View Article : Google Scholar
|
20
|
Choi H, Lee H, Lee SK, Yang B, Chung SJ,
Yeo Y, Park TS, Park DW, Moon JY, Kim TH, et al: Impact of
bronchiectasis on susceptibility to and severity of COVID-19: A
nationwide cohort study. Ther Adv Respir Dis: Feb 14, 2021 (Epub
ahead of print). doi: 10.1177/1753466621995043.
|